Rocket Lab And The Long Path To Profitability (Archive, Full Access)
Rocket Lab faces delayed profitability due to negative incremental margins from vertical integration initiatives.
Latest
26 Jun'26 Portfolio
Increased allocations to biotechnology and pharmaceuticals
Palantir: Scaling This Business Takes More Labor Than The Market Realizes (Archive, Full Access)
Palantir requires labor-intensive custom configuration by engineers, creating an operational bottleneck that limits scalability.
Apple: The Post-Price Hikes Selloff Is An Overreaction (Archive)
Apple shares face limited downside as strong premium demand mitigates price hike risks.
Microsoft Is Paying Too Much In Capex To Drive Revenue Growth (Archive, Full Access)
Microsoft faces impending stock downside as aggressive AI infrastructure expenditures yield negative returns.
Decoding Celestica: How Custom AI Hardware Is The Most Important Catalyst (Archive)
Celestica is uniquely positioned to benefit from hyper-scaler custom AI hardware deployment trends.
SpaceX: Is The Starlink TAM Overstated? A Critical Valuation Review (Archive)
SpaceX faces significant valuation risks despite its growth potential and Starlink market share.